Director Arno Andrew of Insight Molecular (IMDX) receives 32,331-share stock grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Arno Andrew reported acquisition or exercise transactions in this Form 4 filing.
Insight Molecular Diagnostics director Arno Andrew received an equity grant. He was awarded 32,331 shares of Common Stock at a price of $0.00 per share as a grant or award. These Restricted Stock Units vest at the next annual meeting of shareholders, subject to his continued service. Following the grant, he directly holds 168,885 shares and also has 7,804 shares held indirectly through investment LLCs where he has voting and disposition power.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Arno Andrew
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock, no par value | 32,331 | $0.00 | -- |
| holding | Common Stock, no par value | -- | -- | -- |
| holding | Common Stock, no par value | -- | -- | -- |
Holdings After Transaction:
Common Stock, no par value — 168,885 shares (Direct, null);
Common Stock, no par value — 7,804 shares (Indirect, See footnote)
Footnotes (1)
- The Restricted Stock Units shall vest on the date of the next annual meeting of shareholders, subject to the Reporting Person's continued service from the date of grant until the vesting date. These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and, in such capacity, has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here. These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and, in such capacity, has the right to vote and dispose of securities held by MJA, including the shares of Common Stock reported here.
Key Figures
Stock grant size: 32,331 shares
Grant price per share: $0.00 per share
Direct holdings after grant: 168,885 shares
+1 more
4 metrics
Stock grant size
32,331 shares
Common Stock grant coded as acquisition (A)
Grant price per share
$0.00 per share
Reported transaction price for awarded shares
Direct holdings after grant
168,885 shares
Total Common Stock directly owned following transaction
Indirect holdings
7,804 shares
Common Stock held indirectly through investment LLCs
Key Terms
Restricted Stock Units, indirect, annual meeting of shareholders, right to vote and dispose
4 terms
Restricted Stock Units financial
"The Restricted Stock Units shall vest on the date of the next annual meeting of shareholders"
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
indirect financial
"These shares of Common Stock are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA"
right to vote and dispose financial
"has the right to vote and dispose of securities held by JBA, including the shares of Common Stock reported here"
FAQ
What did Insight Molecular Diagnostics (IMDX) director Arno Andrew report on this Form 4?
Director Arno Andrew reported receiving a grant of 32,331 shares of Common Stock at $0.00 per share. The filing also shows his updated direct holdings and indirect holdings through investment LLCs where he has voting and disposition authority.
When do Arno Andrew’s Restricted Stock Units in Insight Molecular Diagnostics (IMDX) vest?
The Restricted Stock Units vest on the date of the next annual meeting of shareholders. Vesting is conditioned on the director’s continued service from the grant date through that annual meeting, according to the footnote disclosure.